First Eagle Investment Management LLC Sells 17,250 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

First Eagle Investment Management LLC lessened its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 41.2% in the fourth quarter, Holdings Channel reports. The firm owned 24,650 shares of the medical instruments supplier’s stock after selling 17,250 shares during the period. First Eagle Investment Management LLC’s holdings in ICU Medical were worth $3,825,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of ICUI. Venturi Wealth Management LLC grew its stake in ICU Medical by 1,510.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 302 shares during the period. Point72 Hong Kong Ltd bought a new position in ICU Medical in the 3rd quarter valued at $72,000. Smartleaf Asset Management LLC grew its stake in ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock valued at $140,000 after purchasing an additional 567 shares during the period. Coldstream Capital Management Inc. bought a new position in ICU Medical in the 3rd quarter valued at $227,000. Finally, OLD National Bancorp IN grew its stake in shares of ICU Medical by 22.0% during the 4th quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock worth $227,000 after acquiring an additional 264 shares during the period. Institutional investors own 96.10% of the company’s stock.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 6.70% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

ICUI has been the subject of several research reports. StockNews.com downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 10th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Finally, Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $168.67.

ICU Medical Stock Up 2.3 %

Shares of NASDAQ ICUI opened at $143.45 on Friday. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The business has a 50-day simple moving average of $157.27 and a two-hundred day simple moving average of $164.95. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.52 billion, a P/E ratio of -31.39 and a beta of 0.73.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.